BACKGROUND: In canine models, transfused older stored red blood cells (RBCs) hemolyze in vivo resulting in significantly increased intravascular cell-free hemoglobin (CFH) and non-transferrin-bound iron (NTBI). During canine bacterial pneumonia with septic shock, but not in controls, older stored RBCs were associated with significantly increased lung injury and mortality. It is unknown if in shock without infection transfusion of older RBCs will result in similar adverse effects. STUDY DESIGN AND METHODS: Two-year-old purpose-bred beagles (n = 12) were transfused similar quantities of either older (42-day) or fresher (7-day) stored universal donor canine RBCs 2.5 hours after undergoing controlled hemorrhage (55 mL/kg). RESULTS: With older transfused RBCs, CFH (p < 0.0001) and NTBI (p = 0.004) levels increased, but lung injury (p = 0.01) and C-reactive protein levels (p = 0.002) declined and there was a trend toward lower mortality (18% vs. 50%). All three deaths after transfused fresher RBCs resulted from hepatic fractures. Lowered exogenous norepinephrine requirements (p < 0.05) and cardiac outputs (p < 0.05) after older transfused RBCs were associated with increased CFH levels that have known vasoconstrictive nitric oxide scavenging capability. CONCLUSIONS: In hemorrhagic shock, older RBCs altered resuscitation physiology but did not worsen clinical outcomes. Elevated CFH may lower norepinephrine requirements and cardiac outputs ameliorating reperfusion injuries. With hemorrhagic shock, NTBI levels persist in contrast to the increased clearance, lung injury, and mortality in the previously reported infection model. These preclinical data suggest that whereas iron derived from older RBCs promotes bacterial growth, worsening septic shock mortality during infection, release of CFH and NTBI during hemorrhagic shock is not necessarily harmful.
BACKGROUND: In canine models, transfused older stored red blood cells (RBCs) hemolyze in vivo resulting in significantly increased intravascular cell-free hemoglobin (CFH) and non-transferrin-bound iron (NTBI). During caninebacterial pneumonia with septic shock, but not in controls, older stored RBCs were associated with significantly increased lung injury and mortality. It is unknown if in shock without infection transfusion of older RBCs will result in similar adverse effects. STUDY DESIGN AND METHODS: Two-year-old purpose-bred beagles (n = 12) were transfused similar quantities of either older (42-day) or fresher (7-day) stored universal donorcanine RBCs 2.5 hours after undergoing controlled hemorrhage (55 mL/kg). RESULTS: With older transfused RBCs, CFH (p < 0.0001) and NTBI (p = 0.004) levels increased, but lung injury (p = 0.01) and C-reactive protein levels (p = 0.002) declined and there was a trend toward lower mortality (18% vs. 50%). All three deaths after transfused fresher RBCs resulted from hepatic fractures. Lowered exogenous norepinephrine requirements (p < 0.05) and cardiac outputs (p < 0.05) after older transfused RBCs were associated with increased CFH levels that have known vasoconstrictive nitric oxide scavenging capability. CONCLUSIONS: In hemorrhagic shock, older RBCs altered resuscitation physiology but did not worsen clinical outcomes. Elevated CFH may lower norepinephrine requirements and cardiac outputs ameliorating reperfusion injuries. With hemorrhagic shock, NTBI levels persist in contrast to the increased clearance, lung injury, and mortality in the previously reported infection model. These preclinical data suggest that whereas iron derived from older RBCs promotes bacterial growth, worsening septic shock mortality during infection, release of CFH and NTBI during hemorrhagic shock is not necessarily harmful.
Authors: Steven M Fiser; Irving L Kron; Stewart M Long; Aditya K Kaza; John A Kern; David C Cassada; Victor E Laubach; Curtis G Tribble Journal: J Heart Lung Transplant Date: 2002-06 Impact factor: 10.247
Authors: Chenell Donadee; Nicolaas J H Raat; Tamir Kanias; Jesús Tejero; Janet S Lee; Eric E Kelley; Xuejun Zhao; Chen Liu; Hannah Reynolds; Ivan Azarov; Sheila Frizzell; E Michael Meyer; Albert D Donnenberg; Lirong Qu; Darrel Triulzi; Daniel B Kim-Shapiro; Mark T Gladwin Journal: Circulation Date: 2011-07-11 Impact factor: 29.690
Authors: Marie E Steiner; Paul M Ness; Susan F Assmann; Darrell J Triulzi; Steven R Sloan; Meghan Delaney; Suzanne Granger; Elliott Bennett-Guerrero; Morris A Blajchman; Vincent Scavo; Jeffrey L Carson; Jerrold H Levy; Glenn Whitman; Pamela D'Andrea; Shelley Pulkrabek; Thomas L Ortel; Larissa Bornikova; Thomas Raife; Kathleen E Puca; Richard M Kaufman; Gregory A Nuttall; Pampee P Young; Samuel Youssef; Richard Engelman; Philip E Greilich; Ronald Miles; Cassandra D Josephson; Arthur Bracey; Rhonda Cooke; Jeffrey McCullough; Robert Hunsaker; Lynne Uhl; Janice G McFarland; Yara Park; Melissa M Cushing; Charles T Klodell; Ravindra Karanam; Pamela R Roberts; Cornelius Dyke; Eldad A Hod; Christopher P Stowell Journal: N Engl J Med Date: 2015-04-09 Impact factor: 91.245
Authors: Jeanne E Hendrickson; Eldad A Hod; Krystalyn E Hudson; Steven L Spitalnik; James C Zimring Journal: Transfusion Date: 2011-06-03 Impact factor: 3.157
Authors: James D Reynolds; Kyla M Bennett; Anthony J Cina; Diana L Diesen; Matthew B Henderson; Faisal Matto; Andrew Plante; Rachel A Williamson; Keivan Zandinejad; Ivan T Demchenko; Douglas T Hess; Claude A Piantadosi; Jonathan S Stamler Journal: Proc Natl Acad Sci U S A Date: 2013-06-24 Impact factor: 11.205
Authors: Dean A Fergusson; Paul Hébert; Debora L Hogan; Louise LeBel; Nicole Rouvinez-Bouali; John A Smyth; Koravangattu Sankaran; Alan Tinmouth; Morris A Blajchman; Lajos Kovacs; Christian Lachance; Shoo Lee; C Robin Walker; Brian Hutton; Robin Ducharme; Katelyn Balchin; Tim Ramsay; Jason C Ford; Ashok Kakadekar; Kuppuchipalayam Ramesh; Stan Shapiro Journal: JAMA Date: 2012-10-10 Impact factor: 56.272
Authors: Jeffrey Wang; Willard N Applefeld; Junfeng Sun; Steve B Solomon; Jing Feng; Zoe G Couse; Thomas F Risoleo; Robert L Danner; Jesús Tejero; Juan Lertora; Elmira Alipour; Swati Basu; Vandana Sachdev; Daniel B Kim-Shapiro; Mark T Gladwin; Harvey G Klein; Charles Natanson Journal: Am J Physiol Heart Circ Physiol Date: 2021-05-14 Impact factor: 4.733
Authors: Dante A Suffredini; Wanying Xu; Junfeng Sun; Jesús Barea-Mendoza; Steven B Solomon; Samuel L Brashears; Andreas Perlegas; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson; Irene Cortés-Puch Journal: Transfusion Date: 2017-06-27 Impact factor: 3.157
Authors: Jaroslav G Vostal; Paul W Buehler; Monique P Gelderman; Abdu I Alayash; Alan Doctor; James C Zimring; Simone A Glynn; John R Hess; Harvey Klein; Jason P Acker; Philip C Spinella; Angelo D'Alessandro; Bernhard Palsson; Thomas J Raife; Michael P Busch; Timothy J McMahon; Marcos Intaglietta; Harold M Swartz; Michael A Dubick; Sylvain Cardin; Rakesh P Patel; Charles Natanson; John W Weisel; Jennifer A Muszynski; Philip J Norris; Paul M Ness Journal: Transfusion Date: 2017-12-15 Impact factor: 3.157
Authors: Jan A Graw; Claire Mayeur; Ivy Rosales; Yumin Liu; Venkata S Sabbisetti; Frank E Riley; Osher Rechester; Rajeev Malhotra; H Shaw Warren; Robert B Colvin; Joseph V Bonventre; Donald B Bloch; Warren M Zapol Journal: Circulation Date: 2016-08-11 Impact factor: 29.690
Authors: Kenneth E Remy; Irene Cortés-Puch; Steven B Solomon; Junfeng Sun; Benjamin M Pockros; Jing Feng; Juan J Lertora; Roy R Hantgan; Xiaohua Liu; Andreas Perlegas; H Shaw Warren; Mark T Gladwin; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson Journal: JCI Insight Date: 2018-09-20
Authors: Brant M Wagener; Parker J Hu; Joo-Yeun Oh; Cilina A Evans; Jillian R Richter; Jaideep Honavar; Angela P Brandon; Judy Creighton; Shannon W Stephens; Charity Morgan; Randal O Dull; Marisa B Marques; Jeffrey D Kerby; Jean-Francois Pittet; Rakesh P Patel Journal: PLoS Med Date: 2018-03-09 Impact factor: 11.069